Clinical trial
ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)
NCT00160680 · UCB S.A. - Pharma Sector, Industry · Completed
Key facts
| NCT number | NCT00160680 |
|---|---|
| Title | ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) |
| Official title | A Pilot, Open, Monocenter, Randomized Two Parallel Groups, Clinical Efficacy Trial: Comparison Continuous Versus on Demand Regimen of Treatment With Levocetirizine 5 mg Oral Tablets, Once a Day, in Adults Suffering From Persistent Allergic Rhinitis (PER) Over 6 Months |
| Lead sponsor | UCB S.A. - Pharma Sector, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | Levocetirizine |
| Enrollment | 62 |
| Start date | Mar 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Aug 31, 2023 |
| Countries | Italy |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: